Scarica l'app Stockscreener
1.80
7.69%
-0.15
Pre-mercato:
1.68
-0.12
-6.67%
Precedente Chiudi:
$1.95
Aprire:
$1.935
Volume 24 ore:
2.27M
Relative Volume:
1.45
Capitalizzazione di mercato:
$6.85M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-0.8411
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
+41.73%
1M Prestazione:
+7.14%
6M Prestazione:
-41.75%
1 anno Prestazione:
-44.62%
Intervallo 1D:
$1.58
$1.95
Intervallo di 1 settimana:
$1.25
$2.28
Portata 52W:
$1.16
$6.25
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Nome
Cyclerion Therapeutics Inc
Settore
Industria
Telefono
617-621-7722
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Confronta CYCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.80 | 7.42M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-20 | Iniziato | Truist | Buy |
| 2021-09-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Iniziato | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie
Top Penny Stocks To Follow Now – January 6th - Defense World
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Top Penny Stocks To Follow NowJanuary 6th - MarketBeat
Exciting Surge in Cyclerion: What’s Next? - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Cyclerion Therapeutics Collaboration Sparks Curiosity - timothysykes.com
Cyclerion, Medsteer form strategic anesthetic technology alliance - TipRanks
Cyclerion Therapeutics stock jumps in premarket after Medsteer deal — what CYCN investors watch next - TechStock²
Morning Market Movers: CYCN, AZI, AEVA, OS See Big Swings - RTTNews
Cyclerion (CYCN) Enters Exclusive Collaboration with Medsteer to Advance CYC-126 Clinical Trials - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Cyclerion partners with Medsteer to advance depression treatment platform By Investing.com - Investing.com Nigeria
Cyclerion Expands Partnership With Medsteer; Plans Phase 2 Trial Of CYC-126 In 2H 2026; Stock Up - Nasdaq
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Benzinga
Cyclerion Therapeutics Inc. (CYCN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cyclerion Therapeutics (CYCN) Enhances Depression Treatment Prog - GuruFocus
Wondering what's happening in today's after-hours session? - Chartmill
Cyclerion partners with Medsteer to advance depression treatment platform - Investing.com India
Cyclerion Therapeutics stock soars after strategic Medsteer collaboration By Investing.com - Investing.com South Africa
Cyclerion Therapeutics stock soars after strategic Medsteer collaboration - Investing.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
New anesthesia-based approach aims to tackle hard-to-treat depression for severe cases - Stock Titan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
ICICI Prudential AMC Ltd (542629) Quarterly Results Are OutMonthly Performance Summary & Superior Wealth Building - bollywoodhelpline.com
Cyclerion Therapeutics Inc Stock Analysis and ForecastDividend Stability Analysis & Turn Bull Runs into Life-Changing Wealth - earlytimes.in
Critical Contrast: Cyclerion Therapeutics (NASDAQ:CYCN) versus Response Genetics (OTCMKTS:RGDXQ) - Defense World
Panjon Limited Flashes Buy Signal on Multi Timeframe ChartMoving Average Crossovers & High Return Wealth Building - bollywoodhelpline.com
Is Cyclerion Therapeutics Inc. stock a safe buy before earningsFibonacci Retracement Levels & Low Cost Trading Ideas - bollywoodhelpline.com
Cyclerion Therapeutics Relaunches with Neuropsychiatric Focus - MSN
Will Cyclerion Therapeutics Inc. stock reach all time highs in 2025Weekly Trend Summary & Reliable Entry Point Alerts - Улправда
Should I hold or sell Cyclerion Therapeutics Inc. stock in 20252025 Geopolitical Influence & Technical Pattern Recognition Alerts - Улправда
How Cyclerion Therapeutics Inc. stock benefits from strong dollarJuly 2025 Institutional & Daily Risk Controlled Trade Plans - Улправда
Rate Hike: Will Cyclerion Therapeutics Inc. stock benefit from upcoming earnings reports2025 Fundamental Recap & Stock Portfolio Risk Management - Улправда
Cyclerion Therapeutics (NASDAQ:CYCN) Shares Down 0.7% – Should You Sell? - Defense World
Cyclerion Therapeutics Earnings Notes - Trefis
Can Cyclerion Therapeutics Inc. stock sustain institutional interestTrade Performance Summary & Safe Swing Trade Setups - Newser
Does Cyclerion Therapeutics Inc. stock trade at a discount to peersWeekly Loss Report & Verified Momentum Watchlists - Newser
How currency fluctuations impact Cyclerion Therapeutics Inc. stockJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - Newser
Cyclerion Therapeutics (CYCN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Cyclerion Therapeutics Inc. stock attractive for growth ETFsPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Cyclerion Receives Milestone Payment from Akebia - TipRanks
Cyclerion Therapeutics Announces Milestone Payment from Akebia - TradingView — Track All Markets
Akebia Therapeutics, Inc. Initiates Phase 2 Clinical Trials for the Treatment of Focused Segmental Glomerulosclerosis Using Praliciguat - marketscreener.com
Cyclerion Therapeutics, Inc. Announces Revision in Its Stock Evaluation Amid Financial Trends - Markets Mojo
How strong is Cyclerion Therapeutics Inc. stock balance sheetBond Market & Real-Time Stock Movement Alerts - newser.com
Will Cyclerion Therapeutics Inc. stock maintain growth story2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionStop Loss & Fast Gain Stock Trading Tips - newser.com
What institutional flow reveals about Cyclerion Therapeutics Inc.Quarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Combining machine learning predictions for Cyclerion Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityRecession Risk & Trade Opportunity Analysis - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analystsEarnings Performance Report & Fast Entry Momentum Trade Alerts - newser.com
Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
28.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):